Snowball logo
logo
SNPH

Santen Pharmaceutical Co

SNPHY β€’ PINK
$11.39+$0.20Β  (1.79%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20222023202420252026TTM
Revenue
Total revenue
266,257279,037301,965300,004309,211.2296,758.3
COGS
109,671112,950123,256128,977138,533.5130,276.6
Gross Profit
156,586166,087178,709171,027170,677.8166,481.7
Operating Expenses & Income
Operating Income
35,886(3,090)38,54146,88047,941.846,531.3
Total Operating Expenses
120,700169,177140,168124,147122,735.9119,950.4
R&D Expenses
26,37728,29725,41624,10327,764.226,667.1
Selling General & Admin Expenses
84,49996,25791,52987,96789,570-
Earnings from Continuing Operations
Interest Expense
(1,209)(1,499)(2,664)(2,716)(2,114.3)(2,015.1)
Interest Income
2,5431,1531,5724,0021,639-
Income Tax Expense
8,4279,1843,17111,62810,476.99,593.3
Net Income
Net Income
27,218(14,948)26,64236,25639,622.639,339.5
Supplemental
EBIT
35,875(4,300)32,53850,19747,941.847,291
EBITDA
52,93012,94950,71668,14567,40766,113.4
In millions of USD, except % and values per 1 share